GLP1R and Abnormal retinal morphology: Beyond gene therapy, other pharmacological approaches, such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), are being explored for their potential benefits in retinal diseases, including diabetic retinopathy [231].